Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | tTF-NGR |
Trade Name | |
Synonyms | |
Drug Descriptions |
tTF-NGR is a fusion protein that comprises truncated tissue factor (tTF) linked to a C-terminal NGR peptide, which binds CD13 and potentially inhibits tumor vasculature and blood flow and reduces tumor growth (PMID: 32517329, PMID: 29110838). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C129984 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Trabectedin + tTF-NGR | Trabectedin tTF-NGR | 0 | 1 |
tTF-NGR | tTF-NGR | 0 | 0 |